Puma Biotechnology (PBYI) Profit After Tax (2010 - 2026)
Puma Biotechnology (PBYI) posted Profit After Tax of -$3.8 million for Q1 2026, down 127.93% on a QoQ basis from $13.4 million in Q4 2025, and down 226.19% year-over-year from $3.0 million in Q1 2025.
Puma Biotechnology (PBYI) Profit After Tax (2010 - 2026) Analysis & Trends
Puma Biotechnology's Profit After Tax history runs 17 years deep, the most recent figure standing at -$3.8 million for Q1 2026.
- Quarterly Profit After Tax fell 226.19% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.4 million (down 35.94% YoY) and the FY2025 annual result came in at $31.1 million, up 2.75% from the prior year.
- Profit After Tax was -$3.8 million for Q1 2026 at Puma Biotechnology, down from $13.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $20.3 million in Q3 2024 and bottomed at -$5.6 million in Q4 2022.
- A 5-year average of $4.7 million and a median of $3.0 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax surged 1710.0% — and 2024, when it sank 443.68%.
- Puma Biotechnology's Profit After Tax stood at -$5.6 million in 2022, then surged by 318.84% to $12.3 million in 2023, then soared by 57.36% to $19.3 million in 2024, then slumped by 30.39% to $13.4 million in 2025, then plunged by 127.93% to -$3.8 million in 2026.
- Business Quant data shows PBYI's Profit After Tax at -$3.8 million in Q1 2026, $13.4 million in Q4 2025, and $8.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | -3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.75 Mn |
| Dec 31, 2025 | 13.44 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 19.31 Mn |
| Sep 30, 2024 | 20.32 Mn |
| Jun 30, 2024 | -4.53 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | -5.61 Mn |
| Sep 30, 2022 | -360,000.00 |
| Jun 30, 2022 | 9.37 Mn |
| Mar 31, 2022 | -3.40 Mn |
| Dec 31, 2021 | 4.22 Mn |
| Sep 30, 2021 | -44.67 Mn |
| Jun 30, 2021 | -5.11 Mn |